State Street’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $294M | Buy |
3,714,029
+123,657
| +3% | +$10.5M | 0.01% | 825 |
|
|
2026
Q1 | $309M | Buy |
3,590,372
+126,527
| +4% | +$11.4M | 0.01% | 739 |
|
|
2025
Q4 | $302M | Buy |
3,463,845
+2,235
| +0.1% | +$170K | 0.01% | 745 |
|
|
2025
Q3 | $198M | Sell |
3,461,610
-11,766
| -0.3% | -$678K | 0.01% | 943 |
|
|
2025
Q2 | $205M | Sell |
3,473,376
-142,147
| -4% | -$9.18M | 0.01% | 898 |
|
|
2025
Q1 | $265M | Buy |
3,615,523
+21,054
| +0.6% | +$1.74M | 0.01% | 740 |
|
|
2024
Q4 | $297M | Buy |
3,594,469
+23,743
| +0.7% | +$1.87M | 0.01% | 723 |
|
|
2024
Q3 | $255M | Buy |
3,570,726
+81,371
| +2% | +$5.74M | 0.01% | 781 |
|
|
2024
Q2 | $239M | Sell |
3,489,355
-88,261
| -2% | -$5.27M | 0.01% | 764 |
|
|
2024
Q1 | $192M | Buy |
3,577,616
+38,596
| +1% | +$2.07M | 0.01% | 887 |
|
|
2023
Q4 | $189M | Sell |
3,539,020
-71,954
| -2% | -$3.51M | 0.01% | 882 |
|
|
2023
Q3 | $179M | Buy |
3,610,974
+1,240,477
| +52% | +$69.4M | 0.01% | 831 |
|
|
2023
Q2 | $141M | Buy |
2,370,497
+85,737
| +4% | +$4.89M | 0.01% | 1002 |
|
|
2023
Q1 | $129M | Buy |
2,284,760
+83,146
| +4% | +$5.33M | 0.01% | 1017 |
|
|
2022
Q4 | $164M | Buy |
2,201,614
+14,076
| +0.6% | +$958K | 0.01% | 847 |
|
|
2022
Q3 | $130M | Sell |
2,187,538
-8,999
| -0.4% | -$542K | 0.01% | 945 |
|
|
2022
Q2 | $123M | Sell |
2,196,537
-22,575
| -1% | -$1.48M | 0.01% | 1025 |
|
|
2022
Q1 | $164M | Buy |
2,219,112
+62,156
| +3% | +$4.32M | 0.01% | 961 |
|
|
2021
Q4 | $156M | Buy |
2,156,956
+39,942
| +2% | +$2.9M | 0.01% | 997 |
|
|
2021
Q3 | $162M | Sell |
2,117,014
-3,032
| -0.1% | -$243K | 0.01% | 956 |
|
|
2021
Q2 | $164M | Buy |
2,120,046
+181,916
| +9% | +$12.9M | 0.01% | 957 |
|
|
2021
Q1 | $120M | Buy |
1,938,130
+13,879
| +0.7% | +$879K | 0.01% | 1101 |
|
|
2020
Q4 | $126M | Buy |
1,924,251
+68,335
| +4% | +$3.93M | 0.01% | 980 |
|
|
2020
Q3 | $91.9M | Sell |
1,855,916
-95,980
| -5% | -$4.95M | 0.01% | 1020 |
|
|
2020
Q2 | $93.1M | Sell |
1,951,896
-595,425
| -23% | -$28.7M | 0.01% | 1011 |
|
|
2020
Q1 | $108M | Buy |
2,547,321
+8,783
| +0.3% | +$434K | 0.01% | 811 |
|
|
2019
Q4 | $149M | Sell |
2,538,538
-29,938
| -1% | -$1.63M | 0.01% | 827 |
|
|
2019
Q3 | $131M | Sell |
2,568,476
-62,382
| -2% | -$2.97M | 0.01% | 850 |
|
|
2019
Q2 | $111M | Buy |
2,630,858
+68,712
| +3% | +$2.98M | 0.01% | 965 |
|
|
2019
Q1 | $127M | Buy |
2,562,146
+88,877
| +4% | +$4.02M | 0.01% | 877 |
|
|
2018
Q4 | $107M | Sell |
2,473,269
-174,839
| -7% | -$8.72M | 0.01% | 867 |
|
|
2018
Q3 | $150M | Buy |
2,648,108
+156,519
| +6% | +$8.24M | 0.01% | 839 |
|
|
2018
Q2 | $126M | Buy |
2,491,589
+65,861
| +3% | +$3.43M | 0.01% | 890 |
|
|
2018
Q1 | $121M | Sell |
2,425,728
-73,540
| -3% | -$3.46M | 0.01% | 900 |
|
|
2017
Q4 | $103M | Buy |
2,499,268
+58,017
| +2% | +$2.03M | 0.01% | 997 |
|
|
2017
Q3 | $72.6M | Buy |
2,441,251
+64,584
| +3% | +$1.97M | 0.01% | 1159 |
|
|
2017
Q2 | $78.8M | Buy |
2,376,667
+129,939
| +6% | +$4.08M | 0.01% | 1086 |
|
|
2017
Q1 | $66.5M | Buy |
2,246,728
+77,604
| +4% | +$2.12M | 0.01% | 1154 |
|
|
2016
Q4 | $53.8M | Buy |
2,169,124
+920,880
| +74% | +$20.9M | 0.01% | 1233 |
|
|
2016
Q3 | $28.2M | Buy |
1,248,244
+94,553
| +8% | +$2.22M | ﹤0.01% | 1543 |
|
|
2016
Q2 | $27.5M | Sell |
1,153,691
-19,453
| -2% | -$467K | ﹤0.01% | 1530 |
|
|
2016
Q1 | $27.9M | Buy |
1,173,144
+39,290
| +3% | +$960K | ﹤0.01% | 1505 |
|
|
2015
Q4 | $31.5M | Buy |
1,133,854
+29,787
| +3% | +$748K | ﹤0.01% | 1421 |
|
|
2015
Q3 | $22.8M | Buy |
1,104,067
+2,829
| +0.3% | +$71.6K | ﹤0.01% | 1658 |
|
|
2015
Q2 | $28.3M | Buy |
1,101,238
+23,423
| +2% | +$593K | ﹤0.01% | 1632 |
|
|
2015
Q1 | $27.2M | Buy |
1,077,815
+26,870
| +3% | +$655K | ﹤0.01% | 1624 |
|
|
2014
Q4 | $25M | Buy |
1,050,945
+24,262
| +2% | +$537K | ﹤0.01% | 1642 |
|
|
2014
Q3 | $20.2M | Sell |
1,026,683
-3,189
| -0.3% | -$65.6K | ﹤0.01% | 1742 |
|
|
2014
Q2 | $24.6M | Buy |
1,029,872
+91,947
| +10% | +$2.22M | ﹤0.01% | 1668 |
|
|
2014
Q1 | $24.9M | Sell |
937,925
-5,686
| -0.6% | -$135K | ﹤0.01% | 1607 |
|
|
2013
Q4 | $19M | Buy |
943,611
+76,334
| +9% | +$1.42M | ﹤0.01% | 1786 |
|
|
2013
Q3 | $15.1M | Buy |
867,277
+88,326
| +11% | +$1.53M | ﹤0.01% | 1876 |
|
|
2013
Q2 | $13.1M | Buy |
+778,951
| New | +$12M | ﹤0.01% | 1893 |
|
Other funds holding GMED
JT
SC
State Street's GMED Position: Q2 2026 in Review
State Street increased its Globus Medical (GMED) stake by 3.4% in Q2 2026, buying an estimated $10.5M and bringing the position to 3,714,029 shares worth $294M. The position accounts for 0.01% of the portfolio, ranked #825.
State Street first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $309M in Q1 2026. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- State Street held 3,714,029 shares of Globus Medical worth $294M as of Q2 2026.
- State Street bought 123,657 Globus Medical shares in Q2 2026, an estimated $10.5M.
- Globus Medical made up 0.01% of State Street's portfolio in Q2 2026, its #825 holding.
- State Street first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
- State Street's Globus Medical position peaked at $309M in Q1 2026.
- 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.